The role of wilms’ tumor gene (wt1) expression as a marker of minimal residual disease in acute myeloid leukemia

HIGHLIGHTS

• who: Davide Lazzarotto and Anna Candoni from the Division of Hematology and Stem Cell Transplantation, ASUFC, University of Udine, Udine, Italy have published the research: The Role of Wilmsu2019 Tumor Gene (WT1) Expression as a Marker of Minimal Residual Disease in Acute Myeloid Leukemia, in the Journal: (JOURNAL)
• what: Based on the expertise with this MRD marker, the authors reassume the main experiences on MRD monitoring with WT1 overexpression, and the authors provide practical guidelines for the optimal dynamic use of this nonspecific molecular MRD marker in AML.
• how: In the study by . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.